`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`MEDIVIS, INC.
`Petitioner
`
`v.
`
`NOVARAD CORP.
`Patent Owner
`
`US Patent No. 11,004,271
`
`Inter Partes Review No. IPR2023-00042
`
`_______________
`
`
`Request for Rehearing Under 37 CFR §42.71(d)(2)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ME1 48062993v.1
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`INTRODUCTION
`The Final Written Decision (FWD) in this IPR overlooked or misapprehended
`
`matters related to the evidence of public accessibility of certain non-patent
`
`references. When properly considered in view of the totality of facts and
`
`circumstances in the record about their public accessibility, Chen (Exhibit 1009)1,
`
`3D-Slicer-Visualization (Exhibit 1007)2, and 3D-Slicer-GUI (Exhibit 1010)3 each
`
`qualify as printed publications.
`
`BACKGROUND
`This IPR began when Medivis petitioned for inter partes review of US Patent
`
`11,004,271 on three grounds. Novarad, the owner of the ‘271 patent, filed no
`
`preliminary response. The Board instituted review on all three grounds and
`
`acknowledged that, among other grounds, “[Medivis] contends that claims 1-6 and
`
`
`1 X. Chen et al., “Development of a Surgical Navigation System Based on
`Augmented Reality Using an Optical See-Through Head-Mounted Display,” 55
`JOURNAL OF BIOMEDICAL INFORMATICS 124-131 (2015) (“Chen”).
`2 S. Pujol, Ph.D. et al., 3D Visualization of DICOM Images for Radiological
`Applications, (Surgical Planning Laboratory, Brigham and Women’s Hospital,
`Boston, Massachusetts 2014) (“3D-Slicer-Visualization,” aka “3D Visualization”)
`(Ex. 1007).
`3 Main Application GUI for 3D Slicer available at https://www.slicer.org/wiki/
`Documentation/4.6/Slicer/Application/MainApplicationGUI (“last edited 7
`November 2016”) (“3D-Slicer-GUI,” aka “3D Slicer”) (Ex. 1010).
`
`ME1 48062993v.1
`
`1
`
`
`
`Patent No. 11,004,271
`
`11-20 would have been obvious over the combined teachings of Doo and Amira, and
`
`Attorney Docket No. 127971-00012
`
`
`
`the combined teachings of Chen, [3D-Slicer-GUI], and [3D-Slicer-Visualization].”
`
`Inst. Dec. 12 (citing Pet. 41-69 and Ex. 1012 ¶¶80-133).
`
`In response to Novarad objections, Medivis timely served declarations and
`
`other evidence as an offer of further proof of the public accessibility of its non-patent
`
`references. Reply, Table of Exhibits (reporting service of Exhibits 1015-1021 and
`
`1023-1024 on May 22, 2023)). With that proof in hand, Novarad nonetheless
`
`asserted that Medivis “offers no proof that any of the asserted documents were in
`
`fact publicly available before the priority date of the ‘271 patent.” POR 19 (July 18,
`
`2023). Implicitly acknowledging the lack of candor in its absolute assertion,
`
`Novarad argued “a copyright notice ... is not enough.” POR 19-20.
`
`As to obviousness of ‘271 patent claims in view of the combined teachings of
`
`Chen, 3D-Slicer-Visualization, and 3D-Slicer-GUI, the FWD “start[ed] and end[ed
`
`the] analysis with public accessibility.” FWD 26. It found that, “[b]ecause
`
`[Medivis] has not shown any of the references of this ground to be publicly
`
`accessible prior art, Petitioner has not proven by a preponderance of evidence that
`
`claims 1-6 and 11-20 would have been obvious over the combination of Chen, [3D-
`
`Slicer-Visualization], and [3D-Slicer-GUI].” FWD 31.
`
`
`
`ME1 48062993v.1
`
`2
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`STANDARD FOR EVALUATION
`“‘[P]ublic accessibility’ [is] the touchstone in determining whether a reference
`
`constitutes a ‘printed publication’ bar under 35 U.S.C. § 102(b).” Hulu, LLC v.
`
`Sound View Innovations, LLC, IPR2018-01039, Paper 29 (PTAB Dec. 20, 2019)
`
`(precedential) at 10 (quoting Blue Calypso, LLC v. Groupon, Inc., 815 F.3d 1331,
`
`1348 (Fed. Cir. 2016)). “A given reference is ‘publicly accessible’ upon a
`
`satisfactory showing that such document has been disseminated or otherwise made
`
`available to the extent that persons interested and ordinarily skilled in the subject
`
`matter or art exercising reasonable diligence, can locate it.” Hulu, at 10-11 (quoting
`
`SRI Int’l, Inc. v. Internet Sec. Sys., Inc., 511 F.3d 1186, 1194 (Fed. Cir. 2008)).
`
`“What constitutes a ‘printed publication’ must be determined in light of the
`
`technology employed.” Hulu, at 10 (citing Samsung Elecs. Co. v. Infobridge Pte.
`
`Ltd., 929 F.3d 1363, 1369 (Fed. Cir. 2019)).
`
`Nonetheless, “the indicia on the face of a reference, such as printed dates and
`
`stamps, are considered part of the totality of the evidence.” Hulu, at 17-18 (citing
`
`Nobel Biocare Servs. AG v. Instradent USA, Inc., 903 F.3d 1365, 1377 (Fed. Cir.
`
`2018)). Applying the law to the facts of record, the Hulu decision—which is
`
`precedential as to how a petitioner may show an asserted reference qualifies as a
`
`printed publication—held that a copyright date, a printing date, an ISBN date, and
`
`ME1 48062993v.1
`
`3
`
`
`
`Patent No. 11,004,271
`
`an established publisher of a series of a similar type of references demonstrate a
`
`Attorney Docket No. 127971-00012
`
`
`
`reasonable likelihood that a book is a printed publication. Hulu, at 19-20.
`
`OVERLOOKED AND MISAPPREHENDED MATTERS
`The FWD did not properly evaluate the public accessibility of Chen (Exhibit
`
`1009), 3D Slicer-Visualization (Exhibit 1007) and 3D Slicer-GUI (Exhibit 1010) in
`
`view of all of the facts and circumstances relevant to their public accessibility of
`
`record with respect to the Petition, the Reply, Novarad’s adopted evidence, and
`
`undisputed facts set forth in Medivis’s Motion to Exclude.
`
`First, the FWD wrongly found that the Petition offers “no proof” that any of
`
`these references were publicly accessible. FWD 26 (citing Pet. 29-30). The FWD’s
`
`citation suggests that finding is based on only two pages of the Petition. But even
`
`those two Petition pages cite evidence that the Hulu tribunal recognized as a type of
`
`evidence that can support a finding that a reference is a printed publication:
`
`including a copyright date, a publication date, and an established publisher of a series
`
`of a similar type of references. Hulu, at 19-20. The Board overlooked or
`
`misapprehended the substance of Hulu’s precedential decision and how that decision
`
`applies to the Petition evidence including, but not limited to, evidence cited on pages
`
`29-30 of the Petition.
`
`Professor Kazanzides qualifies as a person of ordinary skill in the art (POSA),
`
`under both his proposed definition and the Board’s slightly-modified definition. Pet.
`
`ME1 48062993v.1
`
`4
`
`
`
`Patent No. 11,004,271
`
`9-10; FWD 7. The Petition relies on Kazanzides’s knowledge and experience from
`
`Attorney Docket No. 127971-00012
`
`
`
`“teaching, researching, and working in the field of computer-assisted surgery for
`
`nearly 20 years,” as presented in his original declaration. Pet. 9-10 (citing Ex. 1012).
`
`The Petition explained that, “by 2014, the 3D Slicer open-source software
`
`platform for segmentation, registration, and 3D visualization of medical imaging
`
`data was on its fourth major revision.” Pet. 16-17 (citing Ex. 1012 ¶41 and Ex. 1007,
`
`slides 6-7). The www.slicer.org website was known as the source for information
`
`about the “well-known free and open-sourced package named 3D Slicer.” Pet. 54
`
`(citing Ex. 1009, 131 at 1:29-31). Based on his knowledge and experience as an
`
`expert qualified as a POSA, Kazanzides testified that “[a] POSA would have been
`
`familiar with the 3D Slicer application and its ability to load and display data for a
`
`user.” Pet. 16-17 (citing Ex. 1012 ¶41).
`
`Based on his knowledge and experience, Kazanzides further testified that, “in
`
`2014, the Surgical Planning Laboratory (‘SPL’) published examples of 3D data
`
`displayed as individual 2D slices of inner layers of a patient’s anatomy.” Pet. 17-18
`
`(citing Ex. 1012 ¶42 (citing Ex. 1007, slide 39)). Similarly, based on his knowledge
`
`and experience, Kazanzides testified that, “in 2014, the SPL published examples of
`
`3D data displayed as a 3D model of inner layers of a patient’s anatomy.” Pet. 18-19
`
`(citing Ex. 1012 ¶43 (citing Ex. 1007, slide 42)).
`
`ME1 48062993v.1
`
`5
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`Based on his knowledge and experience, Kazanzides also testified that, “[b]y
`
`2016, the 3D Slicer software included published documentation of the Main
`
`Application Graphical User Interface (GUI).” Pet. 55 (citing Ex. 1012 ¶106 (citing
`
`Ex. 1010)). The Board overlooked or misapprehended Kazanzides’s original
`
`testimony cited in the Petition as to the public accessibility of non-patent references
`
`related to 3D Slicer.
`
`In considering Chen (Exhibit 1009), the FWD overlooked or misapprehended
`
`the substance of the Hulu decision as it pertains to Petition evidence of its public
`
`accessibility. The FWD indicates that Medivis cannot rely “in part on the face of
`
`Chen.” FWD 28 (explaining “any reference can state that it was published without
`
`actually being published”). Similarly, the FWD improperly rejected as evidence of
`
`public accessibility the fact that Chen “was published in volume 55 of the
`
`JOURNAL OF BIOMEDICAL INFORMATICS.” Pet. 29-30 (citing Ex. 1009 at
`
`124-131). But the FWD’s approach directly contradicts Hulu’s explanation that “the
`
`indicia on the face of a reference, such as printed dates and stamps, are considered
`
`part of the totality of the evidence.” Hulu, at 17-18. The Board should reconsider
`
`the totality of the evidence as to Chen’s public accessibility with the understanding
`
`from Hulu that indicia on its face are part of the totality of evidence.
`
`ME1 48062993v.1
`
`6
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`Second, the Board overlooked or misapprehended most of the relevant
`
`evidence presented in the Reply.4 The FWD acknowledges that 3D Slicer-GUI
`
`(Exhibit 1010) is “documentation for Slicer software[, which] describes an
`
`application menu, toolbar, data probe, 3D viewer, slice viewers, and chart viewers.”
`
`FWD 26. But finding it somehow unduly burdensome, the Board overlooked
`
`Kazanzides’s cited testimony that 3D Slicer-GUI (Exhibit 1010) is documentation
`
`for Version 4.6 of 3D Slicer, which was released on November 8, 2016. Reply 28
`
`(citing Ex. 1021 ¶¶ 36-38). The Board also either misapprehended or overlooked
`
`the logic that application documentation must be accessible to potential application
`
`users because it serves to help users use the application.
`
`The FWD acknowledges that 3D Slicer-Visualization (Exhibit 1007) is a
`
`“tutorial [that] provides an introduction to the 3D Slicer software, describes 3D data
`
`loading and visualization of images, and describes 3D interactive exploration of the
`
`anatomy.” FWD 25. But finding Kazanzides’s five short cited paragraphs somehow
`
`unduly burdensome, the Board overlooked the cited support for the statement that
`
`
`4 The Board expressed its willingness to consider uncited exhibits, filed
`without explanation, for Novarad’s benefit. Order, Paper 23 (Dec. 11, 2023), 4
`(“At a minimum, we are able to assess the qualifications of [Novarad’s] declarants
`based on their [uncited] curricula vitae.”)). It would be arbitrary and capricious for
`the Board to not be at least as willing to review cited exhibits of similar length for
`Medivis’s benefit.
`
`ME1 48062993v.1
`
`7
`
`
`
`Patent No. 11,004,271
`
`3D Slicer-Visualization (Exhibit 1007) “was available on the internet on September
`
`Attorney Docket No. 127971-00012
`
`
`
`30, 2014.” Reply 27-28 (citing Ex. 1007, 2-124; Ex. 1019; Ex. 1021, ¶¶ 25-29).
`
`Although Hulu found that an established publisher of a series of a similar type of
`
`references to be evidence that a reference is publicly accessible (Hulu at 19-20)—
`
`the FWD found to the contrary that the fact that 3D Slicer’s Director of Training had
`
`presented similar tutorials at 22 conferences to more than 2700 people (Reply 27-28
`
`(citing Ex. 1007, 1-2, 7-8, 14-15, and Ex. 1021 ¶¶11-23)) does not support the public
`
`accessibility of 3D Slicer-Visualization (Exhibit 1007) (FWD 29).
`
`Third, the Board overlooked Novarad’s adoption of the Price Declaration as
`
`its own evidence of the state of the art at the relevant time. Novarad cited the Price
`
`Declaration as evidence of the state of the art at the relevant time. Sur-reply 20-21
`
`(citing the Price Declaration as Ex. 1023). Requesting authorization to file the Price
`
`Declaration later, Novarad represented that it had intended to file the Price
`
`Declaration with its Sur-reply. Order, Paper 23 (Dec. 11, 2023) (hereinafter
`
`“December Order”), 2 (citing “Ex. 3001” (not included in record)). Although the
`
`Board later expunged it as duplicative of Medivis Exhibit 1023, on December 12,
`
`2023, Novarad did file a copy of the Price Declaration as Novarad Exhibit 2023.
`
`Novarad’s designation of the Price Declaration as Exhibit 2023 confirms that
`
`Novarad adopted the Price Declaration as its own evidence of the state of the art. See
`
`37 CFR §42.63(c) (“the patent owner[’s exhibit] range is 2001-2999.”).
`
`ME1 48062993v.1
`
`8
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`The Board overlooked the fact that the Price Declaration addresses the public
`
`accessibility of two petition exhibits: Amira 5 User’s Guide (Exhibit 1005) and 3D
`
`Slicer-Visualization (Exhibit 1007). Although the Price Declaration includes
`
`complete copies of both Petition exhibits, Novarad need not have adopted the Price
`
`Declaration as its own evidence to be able to reference a complete copy of the Amira
`
`5 User’s Guide (Exhibit 1005). For example, the Frank-White Declaration (Exhibit
`
`1024), which was equally available to Novarad, includes a complete copy of the
`
`Amira 5 User’s Guide (Exhibit 1005) but does not reference 3D Slicer-Visualization
`
`(Exhibit 1007). By adopting the Price Declaration as its own evidence of the state
`
`of the art, Novarad waived the right to challenge the Price Declaration and added to
`
`the record evidence of the public accessibility of 3D Slicer-Visualization (Exhibit
`
`1007). Medivis cannot be faulted for not explaining the Price Declaration as
`
`evidence of 3D Slicer-Visualization’s public accessibility because the Board denied
`
`Medivis’s request for additional briefing in view of Novarad’s citation of previously-
`
`uncited new evidence in its Sur-reply. December Order 4.
`
`Fourth, the Board overlooked undisputed facts in Medivis’s Motion to
`
`Exclude (MTE). Rule 42.23(a) requires that any opposition to a motion that
`
`contains a statement of material facts (SOMF) include “a listing of facts that are
`
`admitted, denied, or cannot be admitted or denied” and provides that “[a]ny material
`
`fact not specifically denied may be considered admitted.” Medivis included a SOMF
`
`ME1 48062993v.1
`
`9
`
`
`
`Patent No. 11,004,271
`
`in its MTE and specifically requested that “[a]ny material facts not specifically
`
`Attorney Docket No. 127971-00012
`
`
`
`denied ... be deemed admitted.” MTE 2-7, 15. Medivis’s SOMF should be
`
`considered admitted because Novarad neither denied nor otherwise responded to any
`
`fact presented therein. See generally Opp. to MTE.
`
`As explained in Medivis’s SOMF, Novarad’s expert admitted that multiple
`
`research groups commonly used 3D Slicer technology before the relevant time:
`
`Mulumudi admitted that he was unfamiliar with 3D Slicer visualization
`technology (Ex. 1022, 130:6-8, 131:3-6, 131:7-10) and did not
`recognize Exhibit 1007, 3D Slicer-Visualization (Ex. 1022, 150:10-
`21)—despite Medivis’s citing that exhibit both for the state of the art
`and as part of its third grounds for unpatentability. Pet. 16-19, 54-69.
`Mulumudi agreed that the underlying technology was commonly used
`by multiple research groups before the relevant time and attributed his
`lack of familiarity with 3D Slicer to the fact that he is not involved in
`research. Ex. 1022, 147:13-148:9.
`
`MTE SOMF 6-7. The public availability of the 3D Slicer related references should
`
`be reconsidered in view of that undisputed fact and the inference that groups
`
`commonly using 3D Slicer technology before the relevant time must have had some
`
`way to understand the 3D Slicer technology and to learn how to use it.
`
`CONCLUSION
`Medivis respectfully requests that the Board reconsider the public availability
`
`of Chen (Exhibit 1009), 3D Slicer-GUI (Exhibit 1010), and 3D Slicer-Visualization
`
`ME1 48062993v.1
`
`10
`
`
`
`Patent No. 11,004,271
`
`(Exhibit 1007) based on the overlooked or misapprehended matters identified above.
`
`Attorney Docket No. 127971-00012
`
`
`
`Based on the totality of facts and circumstances of record, including those that were
`
`misapprehended or overlooked, the Board should find that Chen (Exhibit 1009) is
`
`an article that was publicly accessible from the Journal of Biomedical Informatics
`
`and ScienceDirect before the relevant date. Based on the totality of facts and
`
`circumstances of record, including those that were misapprehended or overlooked,
`
`the Board should find that 3D Slicer-GUI (Exhibit 1010) was documentation of a
`
`version of 3D Slicer publicly accessible to potential 3D Slicer users on the
`
`www.slicer.org website before the relevant date to aid in their understanding of the
`
`main graphical user interface (GUI) for that version of 3D Slicer. Similarly, based
`
`on the totality of facts and circumstances of record, including those that were
`
`misapprehended or overlooked, the Board should find that 3D Slicer-Visualization
`
`(Exhibit 1007) was a tutorial by 3D Slicer’s Director of Training publicly accessible
`
`to potential 3D Slicer users on the www.slicer.org website before the relevant date
`
`to help them use 3D Slicer.
`
`
`Respectfully submitted,
`
`
`April 5, 2024
`
`
`
`
`
`
`ME1 48062993v.1
`
`By: /s/ Kia L. Freeman
`
`Kia L. Freeman
`
`Registration No. 47,577
`
`Attorney for Petitioner
`
`
`
`
`
`
`
`11
`
`
`
`
`
`Patent No. 11,004,271
`
`
`
`
`Attorney Docket No. 127971-00012
`
`CERTIFICATE OF SERVICE
`
`
`The undersigned hereby certifies that a copy of the foregoing Request for
`Rehearing was served on April 5, 2024 by transmitting a copy by e-mail to the
`email addresses of the patent owner’s attorneys of record in the patent owner’s
`latest mandatory notice:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`joseph.harmer@tnw.com; and
`hansen@tnw.com
`
`
`By:
`
`
`
`
`
`
`
`
`/s/ Kia Freeman /s/
`
`Kia L. Freeman
`Registration No. 47,577
`Attorney for Petitioner
`
`
`
`ME1 48062993v.1
`
`12
`
`